Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Ankit Shaileshkumar Shah
Introduction
Ankit Shaileshkumar Shah, an accomplished inventor based in Baroda, India, has made significant strides in the field of ophthalmology. With a remarkable total of four patents to his name, Shah is dedicated to advancing medical treatments that enhance patient care and outcomes.
Latest Patents
Among his latest inventions is the ophthalmic solution of difluprednate. This groundbreaking treatment provides an effective method for addressing inflammatory disorders of the eye. The invention involves administering an aqueous solution containing difluprednate at a concentration of 0.02% to 0.04% weight by volume. This innovative solution is designed to be oil-free, enhancing its applicability. Furthermore, it combines a therapeutically effective concentration of difluprednate with a crystal growth inhibitor, which can include polyvinyl alcohol or its derivatives, all delivered in a suitable aqueous vehicle.
Career Highlights
Ankit Shah plays a pivotal role at Sun Pharma Advanced Research Company Limited, where he has been instrumental in driving forward innovative pharmaceutical solutions. His work in the ophthalmology sector has positioned him as a prominent figure, contributing greatly to enhancing the therapeutic options available for various ocular conditions.
Collaborations
Throughout his career, Shah has collaborated with key individuals, including his colleagues Ajay Khopade and Arindam Halder. This teamwork has been essential in the development and refinement of his patented inventions, showcasing the power of collaboration in achieving significant breakthroughs in medical science.
Conclusion
Ankit Shaileshkumar Shah's contributions to the field of ophthalmology through his innovative patents illustrate his commitment to improving medical treatments. With his ongoing research and development efforts, he is poised to make even more substantial impacts in the future, continuing to inspire future generations of inventors and innovators in the pharmaceutical industry.